Patient Perspectives on the Impact of Rare Diseases: Bridging the Commonalities

The Food and Drug Administration (FDA) is hosting a public meeting and an opportunity for public comment on “Patient Perspectives on the Impact of Rare Diseases: Bridging the Commonalities.” This public meeting is intended to obtain patients’ and caregivers’ perspectives on the impacts of rare diseases on daily life and to assess commonalities that may help the Agency and medical product developers to further our understanding and advance the development of treatments for rare diseases. The meeting will take place Click on this link to learn more about how you can participate and view a webcast of the meeting. The webcast is April 29 from 1:00 to 5:00 pm EST.

Click on the link to learn more and register.

© 2019, Pituitary World News. All rights reserved.

LEAVE A REPLY

Please enter your comment!
Please enter your name here